GeneMatrix Inc (109820) — Cash Flow-to-Debt Ratio
GeneMatrix Inc (109820) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of ₩500.19 Million could theoretically repay 0% of its total liabilities (₩9.72 Billion) in one year. Explore GeneMatrix Inc (109820) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GeneMatrix Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for GeneMatrix Inc across 11 annual periods. Also explore GeneMatrix Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GeneMatrix Inc (2014–2024)
Year-by-year debt coverage analysis for GeneMatrix Inc. For market capitalisation and broader financial context, see GeneMatrix Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | ₩-200.12 Million | ₩9.23 Billion | ▲ +92.4% |
| 2023 | -0.29x | ₩-2.35 Billion | ₩8.21 Billion | ▼ -115.6% |
| 2022 | -0.13x | ₩-1.02 Billion | ₩7.72 Billion | ▼ -128.4% |
| 2021 | 0.47x | ₩3.37 Billion | ₩7.21 Billion | ▼ -50.5% |
| 2020 | 0.94x | ₩4.51 Billion | ₩4.78 Billion | ▲ +647.1% |
| 2019 | -0.17x | ₩-2.28 Billion | ₩13.21 Billion | ▼ -30.3% |
| 2018 | -0.13x | ₩-2.74 Billion | ₩20.68 Billion | ▲ +50.1% |
| 2017 | -0.27x | ₩-1.77 Billion | ₩6.68 Billion | ▼ -387.1% |
| 2016 | -0.05x | ₩-373.25 Million | ₩6.85 Billion | ▲ +1.1% |
| 2015 | -0.06x | ₩-591.96 Million | ₩10.74 Billion | ▲ +79.3% |
| 2014 | -0.27x | ₩-1.38 Billion | ₩5.16 Billion | — |